Loading...
CEMENTOS logo

Cementos Bio Bio S.A.SNSE:CEMENTOS Stock Report

Market Cap CL$430.8b
Share Price
CL$1.63k
My Fair Value
n/a
1Y16.5%
7D-0.5%
Portfolio Value
View

Cementos Bio Bio S.A.

SNSE:CEMENTOS Stock Report

Market Cap: CL$430.8b

Cementos Bio Bio (CEMENTOS) Stock Overview

Engages in the production and sale of cement, lime, and concrete products in Chile and internationally. More details

CEMENTOS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends4/6

CEMENTOS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Cementos Bio Bio S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Cementos Bio Bio
Historical stock prices
Current Share PriceCL$1,630.50
52 Week HighCL$2,001.00
52 Week LowCL$1,350.00
Beta-0.31
1 Month Change-10.72%
3 Month Change-9.92%
1 Year Change16.46%
3 Year Change150.85%
5 Year Change126.58%
Change since IPO409.53%

Recent News & Updates

Recent updates

Market Might Still Lack Some Conviction On Cementos Bio Bio S.A. (SNSE:CEMENTOS) Even After 86% Share Price Boost

Nov 20
Market Might Still Lack Some Conviction On Cementos Bio Bio S.A. (SNSE:CEMENTOS) Even After 86% Share Price Boost

The Return Trends At Cementos Bio Bio (SNSE:CEMENTOS) Look Promising

Nov 20
The Return Trends At Cementos Bio Bio (SNSE:CEMENTOS) Look Promising

Investors Shouldn't Be Too Comfortable With Cementos Bio Bio's (SNSE:CEMENTOS) Robust Earnings

Apr 08
Investors Shouldn't Be Too Comfortable With Cementos Bio Bio's (SNSE:CEMENTOS) Robust Earnings

Capital Allocation Trends At Cementos Bio Bio (SNSE:CEMENTOS) Aren't Ideal

Jun 06
Capital Allocation Trends At Cementos Bio Bio (SNSE:CEMENTOS) Aren't Ideal

Is Cementos Bio Bio (SNSE:CEMENTOS) A Risky Investment?

May 10
Is Cementos Bio Bio (SNSE:CEMENTOS) A Risky Investment?

Shareholders Of Cementos Bio Bio (SNSE:CEMENTOS) Must Be Happy With Their 79% Return

Mar 07
Shareholders Of Cementos Bio Bio (SNSE:CEMENTOS) Must Be Happy With Their 79% Return

Be Wary Of Cementos Bio Bio (SNSE:CEMENTOS) And Its Returns On Capital

Feb 14
Be Wary Of Cementos Bio Bio (SNSE:CEMENTOS) And Its Returns On Capital

Is Cementos Bio Bio (SNSE:CEMENTOS) Using Too Much Debt?

Jan 19
Is Cementos Bio Bio (SNSE:CEMENTOS) Using Too Much Debt?

Cementos Bio Bio (SNSE:CEMENTOS) Has Compensated Shareholders With A Respectable 74% Return On Their Investment

Dec 01
Cementos Bio Bio (SNSE:CEMENTOS) Has Compensated Shareholders With A Respectable 74% Return On Their Investment

Shareholder Returns

CEMENTOSCL Basic MaterialsCL Market
7D-0.5%-0.2%0.6%
1Y16.5%20.6%39.5%

Return vs Industry: CEMENTOS underperformed the CL Basic Materials industry which returned 20.6% over the past year.

Return vs Market: CEMENTOS underperformed the CL Market which returned 39.5% over the past year.

Price Volatility

Is CEMENTOS's price volatile compared to industry and market?
CEMENTOS volatility
CEMENTOS Average Weekly Movement2.9%
Basic Materials Industry Average Movement3.0%
Market Average Movement2.8%
10% most volatile stocks in CL Market4.7%
10% least volatile stocks in CL Market1.0%

Stable Share Price: CEMENTOS has not had significant price volatility in the past 3 months compared to the CL market.

Volatility Over Time: CEMENTOS's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1957948Enrique Elsaca Hirmascbb.cl

Cementos Bio Bio S.A. engages in the production and sale of cement, lime, and concrete products in Chile and internationally. The company operates through Cement and Lime segments. It offers ready-mixed concrete, gypsum, and limestone products.

Cementos Bio Bio S.A. Fundamentals Summary

How do Cementos Bio Bio's earnings and revenue compare to its market cap?
CEMENTOS fundamental statistics
Market capCL$430.81b
Earnings (TTM)CL$28.64b
Revenue (TTM)CL$367.24b
15.0x
P/E Ratio
1.2x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CEMENTOS income statement (TTM)
RevenueCL$367.24b
Cost of RevenueCL$228.73b
Gross ProfitCL$138.50b
Other ExpensesCL$109.86b
EarningsCL$28.64b

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)108.39
Gross Margin37.72%
Net Profit Margin7.80%
Debt/Equity Ratio32.9%

How did CEMENTOS perform over the long term?

See historical performance and comparison

Dividends

4.9%
Current Dividend Yield
78%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/26 22:59
End of Day Share Price 2025/11/25 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cementos Bio Bio S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.